Redx Pharma PLC
Small-molecule drugs for unmet needs
This article was originally published in Start Up
Redx Pharma PLC and its subsidiaries are focused on developing proprietary, small-molecule therapeutics to address areas of high unmet medical need principally in cancer, infection and autoimmune disease.
Register for our free email digests: